BLSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bullish (BLSH) does not present a strong buy opportunity at this time for a beginner investor with a long-term focus. The company's financial performance is weak, with significant YoY declines in revenue, net income, and EPS. While technical indicators like MACD and RSI suggest a neutral to slightly positive trend, the lack of strong trading signals, weak analyst sentiment, and absence of recent positive catalysts make this stock a hold rather than a buy.
The MACD histogram is positive at 0.583 and expanding, indicating a slightly bullish momentum. RSI is neutral at 61.96, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are at S1: 30.238 and R1: 33.118, with the current price near resistance levels, limiting upside potential.
NULL identified. No recent news or legislative catalysts. Analysts maintain buy ratings despite lowering price targets, indicating some long-term optimism.
Weak financial performance in Q4 2025 with significant YoY declines in revenue (-2.55%), net income (-445.95%), and EPS (-441.51%). Gross margin also dropped by 25%. Analysts have consistently lowered price targets, citing a risk-off environment and weak investor sentiment. No significant hedge fund or insider trading activity. Congress trading data is unavailable.
In Q4 2025, revenue declined by 2.55% YoY to $64.35 billion. Net income dropped significantly to -$546.6 million (-445.95% YoY), and EPS fell to -3.62 (-441.51% YoY). Gross margin decreased to 0.03 (-25% YoY), indicating poor profitability.
Analysts have lowered price targets recently, with Clear Street reducing its target from $50 to $42 while maintaining a Buy rating. JPMorgan lowered its target from $42 to $41 with a Neutral rating. Citi reduced its target from $77 to $67 but remains optimistic about the sector in 2026. Overall, sentiment is mixed, with a cautious outlook.
